Cargando…
Transcription activated p73-modulated cyclin D1 expression leads to doxorubicin resistance in gastric cancer
Gastric cancer (GC) is one of the leading types of cancer in terms of mortality cases worldwide. Doxorubicin (Dox), a common chemotherapy drug, is frequently used to treat GC; however, acquired resistance to Dox hinders the chemotherapeutic outcome and causes shorter survival in GC patients. Several...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776556/ https://www.ncbi.nlm.nih.gov/pubmed/29434772 http://dx.doi.org/10.3892/etm.2017.5642 |